Title:
ＲＡＳ媒介性疾患を処置または予防する方法
Document Type and Number:
Japanese Patent JP6763858
Kind Code:
B2
Abstract:
Disclosed are compounds, for example, a compound of formula I,wherein R, R0, R1-R8, n, X, Y, Y', and E are as described herein, pharmaceutical compositions containing such compounds, and methods of treating or preventing a disease or condition for example, cancer, mediated by therasgene.
Inventors:
Piazza, Gary A.
Chain, sea
Keaton, Adam Bee.
Boyd, Michael Earl.
Chain, sea
Keaton, Adam Bee.
Boyd, Michael Earl.
Application Number:
JP2017533502A
Publication Date:
September 30, 2020
Filing Date:
December 16, 2015
Export Citation:
Assignee:
AD Pharmaceuticals, LRC
International Classes:
A61K31/165; A61K31/167; A61K31/341; A61K31/36; A61K31/40; A61K31/4178; A61K31/422; A61K31/4406; A61K31/443; A61K31/4439; A61K31/444; A61K31/4545; A61P35/00; A61P35/04; A61P43/00
Domestic Patent References:
| JP2013518060A | ||||
| JP2000514417A |
Other References:
Mol.Cancer Ther.,2006年,Vol.5,No.1,pp.60-67
Int.J.Cancer,2000年,Vol.87,pp.155-164
Int.J.Cancer,2000年,Vol.87,pp.155-164
Attorney, Agent or Firm:
Hidesaku Yamamoto
Natsuki Morishita
Takatoshi Iida
Daisuke Ishikawa
Kensaku Yamamoto
Natsuki Morishita
Takatoshi Iida
Daisuke Ishikawa
Kensaku Yamamoto